Cinética dos anticorpos anti-HLA no pós-transplante renal - impacto na rejeição aguda do enxerto

No abstract is available for this paper.

• Publication year

  2014

• Venue

  Unknown venue

• Publication date

  2014-11-06

• Fields of study

  Not labeled

• Identifiers
  DOI 10.11606/T.5.2014.TDE-21012015-152131
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• De Novo Donor-Specific Human Leukocyte Antigen Antibodies Early After Kidney Transplantation

  2014cited by this paper
• Antibody-mediated vascular rejection of kidney allografts: a population-based study.

  2013cited by this paper
• Transplantation: Donor-specific HLA antibodies and renal allograft failure

  2013cited by this paper
• Pathology of C4d-negative antibody-mediated rejection in renal allografts

  2013cited by this paper
• Incidence and Impact of De Novo Donor-Specific Alloantibody in Primary Renal Allografts

  2013cited by this paper
• Consensus Guidelines on the Testing and Clinical Management Issues Associated With HLA and Non-HLA Antibodies in Transplantation

  2013cited by this paper
• Preformed Donor-Specific Antibodies and Risk of Antibody-Mediated Rejection in Repeat Renal Transplantation

  2013cited by this paper
• Complement-binding anti-HLA antibodies and kidney-allograft survival.

  2013cited by this paper
• Evolution and Clinical Pathologic Correlations of De Novo Donor‐Specific HLA Antibody Post Kidney Transplant

  2012cited by this paper
• Detection and clinical relevance of donor specific HLA antibodies: a matter of debate

  2012cited by this paper
• Significance of C4d Banff Scores in Early Protocol Biopsies of Kidney Transplant Recipients with Preformed Donor‐Specific Antibodies (DSA)

  2011cited by this paper
• Inferior Kidney Allograft Outcomes in Patients With De Novo Donor-Specific Antibodies Are Due to Acute Rejection Episodes

  2011cited by this paper
• C4d-negative antibody-mediated rejection in renal allografts: evidence for its existence and effect on graft survival.

  2011cited by this paper
• C4d staining in post-reperfusion renal biopsy is not useful for the early detection of antibody-mediated rejection when CDC crossmatching is negative.

  2011cited by this paper
• Banff ’09 Meeting Report: Antibody Mediated Graft Deterioration and Implementation of Banff Working Groups

  2010cited by this paper
• Screening for De Novo Anti-Human Leukocyte Antigen Antibodies in Nonsensitized Kidney Transplant Recipients Does Not Predict Acute Rejection

  2010cited by this paper
• Detection of donor-specific HLA antibodies before and after removal of a rejected kidney transplant.

  2010cited by this paper
• Preexisting donor-specific HLA antibodies predict outcome in kidney transplantation.

  2010cited by this paper
• Virtual crossmatch by identification of donor-specific anti-human leukocyte antigen antibodies by solid-phase immunoassay: a 30-month analysis in living donor kidney transplantation.

  2010cited by this paper
• Reducing De Novo Donor‐Specific Antibody Levels during Acute Rejection Diminishes Renal Allograft Loss

  2009cited by this paper
• Relevância da monitorização dos anticorpos anti-HLA após o transplante renal: estudo clínico e anatomopatológico

  2009cited by this paper
• Clinical significance of anti-HLA antibodies detected by Luminex: enhancing the interpretation of CDC-BXM and important post-transplantation monitoring tools.

  2009cited by this paper
• Endothelial Gene Expression in Kidney Transplants with Alloantibody Indicates Antibody‐Mediated Damage Despite Lack of C4d Staining

  2009cited by this paper
• Clinical relevance of preformed HLA donor-specific antibodies in kidney transplantation.

  2008cited by this paper
• Detection of alloantibodies using a sensitive antiglobulin microcytotoxicity test: identification of low levels of pre-formed antibodies in accelerated allograft rejection.

  2008cited by this paper
• Methods for histocompatibility testing in the early 21st century

  2007cited by this paper
• Banff '05 Meeting Report: Differential Diagnosis of Chronic Allograft Injury and Elimination of Chronic Allograft Nephropathy (‘CAN’)

  2007cited by this paper
• Antibody-mediated renal allograft rejection: diagnosis and pathogenesis.

  2007cited by this paper
• Allorecognition and the alloresponse: clinical implications.

  2007cited by this paper
• The Effect of Antithymocyte Globulin on Anti–Human Leukocyte Antigen Antibody Detection Assays

  2007cited by this paper
• C4d and C3d Staining in Biopsies of ABO‐ and HLA‐Incompatible Renal Allografts: Correlation with Histologic Findings

  2006cited by this paper
• Presensitization: the problem and its management.

  2006cited by this paper
• Clinical importance of non-HLA antibodies in solid organ transplantation

  2006cited by this paper
• Post‐Transplant Anti‐HLA Class II Antibodies as Risk Factor for Late Kidney Allograft Failure

  2006cited by this paper
• Detection of anti-HLA antibodies with flow cytometry in needle core biopsies of renal transplants recipients with chronic allograft nephropathy.

  2005cited by this paper
• Development of Posttransplant Antidonor HLA Antibodies Is Associated with Acute Humoral Rejection and Early Graft Dysfunction

  2005cited by this paper
• Prevalence and significance of anti‐HLA and donor‐specific antibodies long‐term after renal transplantation

  2005cited by this paper
• Frequency and clinical implications of development of donor-specific and non-donor-specific HLA antibodies after kidney transplantation.

  2005cited by this paper
• Humoral Rejection of Organ Allografts

  2005cited by this paper
• Detectable circulating antiendothelial cell antibodies in renal allograft recipients with C4d-positive acute rejection: a report of three cases.

  2005cited by this paper
• Induction versus noninduction therapy in kidney transplantation: considering different PRA levels and different induction therapies.

  2004cited by this paper
• Consensus Opinion from the Antibody Working Group on the Diagnosis, Reporting, and Risk Assessment for Antibody-Mediated Rejection and Desensitization Protocols

  2004cited by this paper
• Predicting Kidney Graft Failure by HLA Antibodies: a Prospective Trial

  2004cited by this paper
• RENAL TRANSPLANTATION USING LIVING DONORS WITH A POSITIVE CROSSMATCH: CAN WE PREDICT EFFICACY OF DESENSITIZATION WITH IVIG BY AN “IN VITRO” TEST?

  2004cited by this paper
• Antibody‐Mediated Rejection Criteria – an Addition to the Banff ′97 Classification of Renal Allograft Rejection

  2003cited by this paper
• Immunologic monitoring

  2003cited by this paper
• Complement C4d in Graft Capillaries – the Missing Link in the Recognition of Humoral Alloreactivity

  2003cited by this paper
• Posttransplantation production of donor HLA-specific antibodies as a predictor of renal transplant outcome1

  2003cited by this paper
• Effector mechanisms in transplant rejection

  2003cited by this paper
• Pre‐Transplant Assessment of Donor‐Reactive, HLA‐Specific Antibodies in Renal Transplantation: Contraindication vs. Risk

  2003cited by this paper
• Humoral Theory of Transplantation

  2003cited by this paper
• Kidney graft failure and presensitization against HLA Class I and Class II antigens1

  2002cited by this paper
• All chronic rejection failures of kidney transplants were preceded by the development of HLA antibodies

  2002cited by this paper
• Humoral rejection in kidney transplantation: new concepts in diagnosis and treatment

  2002cited by this paper
• Desensitization and Subsequent Kidney Transplantation of Patients Using Intravenous Immunoglobulins (IVIg)

  2002cited by this paper
• Clinical Significance of MHC‐Reactive Alloantibodies that Develop after Kidney or Kidney–pancreas Transplantation

  2002cited by this paper
• Capillary C4d deposition in kidney allografts: a specific marker of alloantibody-dependent graft injury.

  2002cited by this paper
• ACUTE HUMORAL REJECTION IN RENAL ALLOGRAFT RECIPIENTS: I. INCIDENCE, SEROLOGY AND CLINICAL CHARACTERISTICS1

  2001cited by this paper
• IMPACT OF DONOR-SPECIFIC ANTIBODIES ON CHRONIC REJECTION OCCURRENCE AND GRAFT LOSS IN RENAL TRANSPLANTATION: POSTTRANSPLANT ANALYSIS USING FLOW CYTOMETRIC TECHNIQUES1

  2001cited by this paper
• Impact of humoral alloreactivity early after transplantation on the long-term survival of renal allografts.

  2001cited by this paper
• Sensitization and sensitivity: defining the unsensitized patient.

  2000cited by this paper
• Anti-HLA antibodies after solid organ transplantation.

  2000cited by this paper
• The Banff 97 working classification of renal allograft pathology.

  1999cited by this paper
• Acute vascular rejection: a clinical and morphological study

  1998cited by this paper
• The role of T-cell costimulatory activation pathways in transplant rejection.

  1998cited by this paper
• Identification of patients at high risk of graft loss by pre- and posttransplant monitoring of anti-HLA class I IgG antibodies by enzyme-linked immunosorbent assay.

  1997cited by this paper
• Evaluation of pathologic criteria for acute renal allograft rejection: reproducibility, sensitivity, and clinical correlation.

  1997cited by this paper
• The use of magnetic beads coated with soluble HLA class I or class II proteins in antibody screening and for specificity determinations of donor-reactive antibodies.

  1996cited by this paper
• Pathologic features of acute renal allograft rejection associated with donor-specific antibody, Analysis using the Banff grading schema.

  1996cited by this paper
• VARIATIONS OF THE LYMPHOCYTOTOXICITY TEST AN EVALUATION OF SENSITIVITY AND SPECIFICITY

  1995cited by this paper
• Chapter 7 Flow Cytometry Crossmatching for Solid Organ Transplantation

  1994cited by this paper
• Mechanisms of T cell recognition of alloantigen. The role of peptides.

  1994cited by this paper
• The detection and relevance of pretransplant antibodies.

  1994cited by this paper
• Capillary deposition of C4d complement fragment and early renal graft loss.

  1993cited by this paper
• ENZYME‐LINKED IMMUNOASSAY FOR ANTI‐HLA ANTIBODIES—AN ALTERNATIVE TO PANEL STUDIES BY LYMPHOCYTOTOXICITY

  1993cited by this paper
• THE SIGNIFICANCE OF THE ANTI–CLASS I RESPONSE

  1992cited by this paper
• Posttransplant antidonor antibodies and graft rejection. Evaluation by two-color flow cytometry.

  1989cited by this paper
• Two types of murine helper T cell clone. I. Definition according to profiles of lymphokine activities and secreted proteins.

  1986cited by this paper
• Assessment of the risk for broad sensitization by blood transfusions.

  1984cited by this paper
• Significance of the positive crossmatch test in kidney transplantation.

  1969cited by this paper
• A simple micro cytotoxicity test.

  1969cited by this paper
• Hyperacute rejection of kidney allografts, associated with pre-existing humoral antibodies against donor cells.

  1966cited by this paper

• No citing papers are available for this paper.